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Summary and conclusions All the men living in Malmo born in 1926-9 were invited for a screening examination which included an assessment of alcohol consumption and measurement of gammaglutamyltransferase (GGT) activity. They were followed for up to four years (median 2) and their mortality assessed. Sixty-two deaths occurred, 41 (0-9%) among the 4571 men who attended the screening investigation and 21 (1-3%) among the 1609 who did not respond to the invitation. Evidence of alcohol abuse or an alcoholrelated cause of death was present in 25 (61%) of the deaths among the attenders and 13 (62%) of those among the non-responders. GGT values at the screening investi-
Introduction
Though alcohol is recognised to be a major contributory factor in disease and premature death among middle-aged men, the medical profession still tends to underestimate the importance of alcohol in the range of disease.' There have been demands for a "public health strategy" to identify and prevent alcohol abuse through screening2 3 . and for powerful political and economic measures to curb consumption. An important prerequisite for any of these measures is increased knowledge of the medical complications of alcohol consumption.
We established a screening clinic to try to identify and prevent alcohol abuse, and we report here a study on the short-term mortality of middle-aged men who were invited for screening. incidence of alcohol-related deaths, and a higher incidence of attendance at the alcoholic clinic among the non-responders than among those who attended the screening clinic (table IV) . Nevertheless, over half the attenders had a history of heavy alcohol consumption and about half had raised GGT activities. Altogether 25 (61 %) of the attenders had a history of alcohol consumption or raised GGT values, or both. 
Discussion
In this unselected population of Swedish urban men alcohol was the most important single factor associated with death at about the age of 50: an alcohol-positive history was present in over half the men who died. Our study was a short-term prospective study of mortality in a fairly large population, uniform for age and sex, who were invited for screening and followed for up to four years (median two years). Our analysis of alcohol consumption was partly prospective and partly retrospective.
Many studies have confirmed the general impression that alcoholics have increased morbidity and mortality,l 2 5-8 and such features should also be identified in population studies. Nevertheless, few population studies have been performed because of the difficulties of measuring alcohol consumption. Reliance on self-reported consumption in questionnaires makes findings open to doubt. At our screening investigation we used a modified Michigan alcoholism screening test,3 4 but we also used a biochemical index of heavy alcohol consumption.
With methods partly comparable to ours Tibblin studied 2992 men living in Gothenberg who were born in 1913.5-7 He found that of the 273 who died aged 35-55 17% were heavy drinkers or died from alcohol-related conditions.7 Lannerstad examined 49 deaths that occurred among 802 men in Malmo at the age of 55-60 years; in 2700 he found signs of alcohol abuse, defined as registration at the alcohol clinic or a blood alcohol concentration at necropsy of more than 22 mmol/l, or both.8
The American epidemiological studies in Framingham and at Chicago Western Electric Company also showed an association between alcoh'ol consumption and all causes of death,9 10 but comparisons are difficult because these populations were selected and the ages were different. Serum GGT activity has been shown in series of alcoholics"1-13 and in population studies4 [14] [15] [16] [17] clinics complain of muscle weakness, tiredness, and general malaise. The next commonest group are patients who appear to be completely asymptomatic but in whom hypercalcaemia is found by chance during investigations for other problems. With the increased recognition of the disease, many elderly patients have been found to have hyperparathyroidism. In such patients the non-specific nature of the symptoms may readily be attributed to "aging," and the decision to operate may be difficult. We report our experience of parathyroidectomy in 12 patients aged 70 or over, which encourages us to recommend operations in symptomatic patients in this age group.
Patients, methods, and results
The table gives the details of the 12 patients. The commonest symptoms were muscle weakness, mental slowing, and decreased mobility. Before operation, three of the patients (cases 2, 7, and 8) were unable to manage at home and were awaiting long-term hospital care, while two others (cases 5 and 11) were able to live at home only because of considerable attention from relatives living in the same house. Another patient (case 6) had been transferred to sheltered accommodation before operation. In all 12 patients the hypercalcaemia was discovered during routine biochemical investigations for assessment of deteriorating physical state or for completely unrelated medical problems. Hyperparathyroidism was diagnosed when persistent hypercalcaemia was present with raised serum parathyroid hormone concentrations. No patient showed radiological evidence of the disease. At operation a single parathyroid adenoma was found in all cases except case 10, in which two adenomas were removed at separate operations. Successful removal of the adenomas was associated with rapid return of the serum calcium concentration to normal. The operation was well tolerated by all the patients, and no serious complications occurred. Only one patient (case 5) developed severe symptomatic hypocalcaemia. Although mild asymptomatic hypocalcaemia often occurred after operation, all patients eventually achieved normocalcaemia without long-term treatment with calcium supplements or vitamin D.
